stella
beta
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Stella
Home
/
Nonalcoholic Fatty Liver Disease
/
View on ClinicalTrials.gov
Recruiting
Back to Nonalcoholic Fatty Liver Disease trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(3 sites)
United Kingdom
Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham
Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust, Nottingham
University of Nottingham, Nottingham
Follow this trial
Get notified in plain English when this trial's status changes. No account required.
Follow